Borrar Mensaje Tyree
email  [email protected]
www  http://retapuit.ee/hinnakiri
Fecha  14/11/2015 11:41
  • Host: 188.143.232.34
  • IP: 188.143.232.34
  • Navegador: Internet Explorer 6.x
  • S.O.: Windows XP

ynWyveTOlgtVZQJui
In a meeting http://www.monaghanpeace.ie/calendar/ restless stendra doesn't work damage Under the terms of the agreement, the Swiss major will pay $10 million upfront, plus development and commercial milestones of up to $412.5 million for exclusive access to two of Inovio's DNA-based immunotherapies - INO-5150 for prostate cancer and INO-1800 for hepatitis B. The US firm is also entitled to up to double-digit tiered royalties.
                                                                                                                                                                                                                                                                                                                               





Volver al foro

Responder


¿Quien eres?
EMail
Titulo
Link a tu Web
Te enviamos un email
     cuando tu mensaje sea contestado
Mensaje